SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions, Inc. announced today the appointment of Kurt Nielsen, Ph.D. as Chief Technology Officer and Senior Vice President, Innovation and Growth, effective immediately. Dr. Nielsen will have responsibility for driving innovation activities and investments across Catalent’s broad range of advanced dose forms and packaging technologies. Dr. Nielsen will report to John Chiminski, President and CEO of Catalent, and will be based in Catalent’s global headquarters in Somerset, New Jersey.
